Exclusive Interview with Dr. Raymond Miller at Neoantigen-Based Therapies Summit

GenScript and Hanson Wade’s Neoantigen Based Therapies Summit Present an Exclusive Interview with Dr. Raymond Miller.

Raymond Miller Ph.D. is a Senior Global Product Manager with GenScript managing customized reagent services used in molecular diagnostics and therapeutics research.He earned his Ph.D. in Biochemistry and Molecular Biology at Virginia Polytechnic Institute and State University studying the differences in olfaction using comparative genomics approaches. Dr. Miller has almost 10 years of life science industry experience in the development and support of a wide range of proteomics and genomics products in several organizations including Bio-Rad Laboratories, Agilent Technologies, and GenScript. His current focus is on market research, product development, and commercialization strategy for therapeutic materials used in cell and gene therapies along with molecular diagnostics.

In This Interview Dr. Miller Will Discuss

Why the neoantigen field is such an area of interest amongst the cancer immunotherapy community;

Why GenScript has decided to enter into the world of neoantigen-based therapeutics;

Current neoantigen thought leaders GenScript has synthesized neoantigen peptides with;

What makes GenScript’s work with neoantigens unique compared to other key players in this field.

Read the full interview here!